252 related articles for article (PubMed ID: 38237858)
1. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
2. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
3. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
4. Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma.
Lipworth B; Kuo CR; Stewart K; Chan R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):889-893. PubMed ID: 38346474
[TBL] [Abstract][Full Text] [Related]
5. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
Beasley R; Bruce P; Houghton C; Hatter L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
[TBL] [Abstract][Full Text] [Related]
6. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
[TBL] [Abstract][Full Text] [Related]
7. The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations.
Panettieri RA; Chipps BE; Skolnik N; George M; Murphy K; Lugogo N
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):882-888. PubMed ID: 38316182
[TBL] [Abstract][Full Text] [Related]
8. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
9. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
Kew KM; Karner C; Mindus SM; Ferrara G
Cochrane Database Syst Rev; 2013 Dec; (12):CD009019. PubMed ID: 24343671
[TBL] [Abstract][Full Text] [Related]
10. The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
Buhl R; Kuna P; Peters MJ; Andersson TL; Naya IP; Peterson S; Rabe KF
Respir Res; 2012 Jul; 13(1):59. PubMed ID: 22816878
[TBL] [Abstract][Full Text] [Related]
11. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
[TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
Buhl R; Vogelmeier C
Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
[TBL] [Abstract][Full Text] [Related]
13. Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.
Krings JG; Sekhar TC; Chen V; Blake KV; Sumino K; James AS; Clover AK; Lenze EJ; Brownson RC; Castro M
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2767-2777. PubMed ID: 37245736
[TBL] [Abstract][Full Text] [Related]
14. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
Cates CJ; Karner C
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
[TBL] [Abstract][Full Text] [Related]
15. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
16. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
[TBL] [Abstract][Full Text] [Related]
18. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
[TBL] [Abstract][Full Text] [Related]
19. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
[TBL] [Abstract][Full Text] [Related]
20. Stepping Away from the Blue Inhaler in Asthma Management - A Paradigm Shift.
Dhar R; Vora A
J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
